Logo

Unilever to Use Cognia s Software for Drug Discovery

Mar 07, 2005

NEW YORK, March 7 (GenomeWeb News) - Unilever will use data-management software developed by Cognia, the companies said today.

 

Researchers at Unilever's Target Identification and Validation Team will use the software, called Cognia Molecular, to help them "share and institutionalize [its] research information" by capturing, integrating, managing, and using biological and chemical information relevant to drug discovery, Cognia said.

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.